Oral formulation of selinexor, a selective inhibitor of nuclear export, applied in oncology for relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma treatments. Sourced by pharmaceutical wholesalers, hospitals, and oncology clinics for specialized cancer care protocols.